Physiology and pathophysiology of nitric oxide in the nervous system, with special mention of the islands of Calleja and the circunventricular organs.
Nitric oxide (NO) has been recognized as a key regulatory factor in many physiological processes, including central nervous system function, development, and phatophysiology. NO is produced by a class of enzymes known as NO synthases (NOS) and in normal adult animals only the neuronal isoform (nNOS) is detectable. During cortical development, nNOS was found at E14 in neuroblasts of the marginal zone and its expression raised to a zenith by P5, decreasing afterwards until reaching a steady level by P10. At that time, nNOS was found mainly in pyramidal neurons. Interestingly, the inducible isoform of the enzyme (iNOS) was also active from P3 to P7, but it disappeared almost completely by P20. The neurodegeneration observed during normal aging and following hypoxic accidents seems to be the result of cumulative free radical damage, and excessive production of NO may be at the basis of the cascade. After ischemic events we observed an elevation in the number of neurons expressing nNOS coincident with an elevation in Ca2+-dependent NOS activity for up to 120 min. After this period, nNOS activity began to decrease but it was substituted by a rapid increase in Ca2+-independent activity coincident with the histological appearance of previously undetectable iNOS-immunoreactive neurons. These increases in NO production were accompanied by specific patterns of protein nitration, a process that seems to result in loss of protein function. In particular, we observed a correlation between exposure to ischemia-reperfusion and nitration of cytochrome c. This process was coincident with the exit of the cytochrome from the mitochondria to the surrounding cytoplasm, an early event in neuronal apoptosis. Interestingly, most of the morphological and molecular changes associated with ischemic damage were prevented by treatment with inhibitors of NO production, indicating a clear path in the search for efficacious drugs in the battle against cerebrovascular accidents.
Rodrigo
J
J
Department of Neuroanatomy and Cell Biology, Instituto Cajal, CSIC, Madrid, Spain. rodmart@cajal.csic.es
Alonso
D
D
Bentura
M L
ML
Castro-Blanco
S
S
Encinas
J M
JM
Fernández
A P
AP
Fernández-Vizarra
P
P
Richart
A
A
Santacana
M
M
Serrano
J
J
Martínez
A
A
D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000473:pathology*; D016923:Cell Death; D002490:Central Nervous System / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D000860:Hypoxia; D007150:Immunohistochemistry; D007511:Ischemia; D020670:Islands of Calleja / Q000378:metabolism / Q000473:pathology*; D009420:Nervous System / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism*; D051381:Rats; D015427:Reperfusion Injury; D020521:Stroke
D009569:Nitric Oxide